• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肝硬化的消退。形态学特征及不完全间隔性肝硬化的发生机制。

Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

作者信息

Wanless I R, Nakashima E, Sherman M

机构信息

Department of Laboratory Medicine and Pathobiology, Toronto General Hospital and University of Toronto, Ontario, Canada.

出版信息

Arch Pathol Lab Med. 2000 Nov;124(11):1599-607. doi: 10.5858/2000-124-1599-ROHC.

DOI:10.5858/2000-124-1599-ROHC
PMID:11079009
Abstract

CONTEXT

Cirrhosis is widely regarded as being irreversible. Recent studies have demonstrated that fibrosis may decrease with time in humans and experimental animals if the disease activity becomes quiescent. The histologic appearance of regressing cirrhosis in the human has not been described in detail.

OBJECTIVES

To define histologic parameters that indicate regression of cirrhosis and to provide an interpretation of how regression occurs from a histologic point of view.

DESIGN

A patient who underwent a series of biopsies that showed apparent regression of hepatitis B cirrhosis is presented. In addition, 52 livers removed at transplantation having cirrhosis or incomplete septal cirrhosis were graded for histologic parameters that suggest progression or regression of fibrosis. Progression parameters were steatohepatitis, inflammation, bridging necrosis, and piecemeal necrosis. The regression parameters (collectively called the hepatic repair complex) were delicate perforated septa, isolated thick collagen fibers, delicate periportal fibrous spikes, portal tract remnants, hepatic vein remnants with prolapsed hepatocytes, hepatocytes within portal tracts or splitting septa, minute regenerative nodules, and aberrant parenchymal veins.

RESULTS AND CONCLUSIONS

Regression parameters were found in all livers and were prominent in the majority. Livers with micronodular cirrhosis, macronodular cirrhosis, and incomplete septal cirrhosis demonstrate a histologic continuum. A continuum of regressive changes was also seen within individual livers. These appearances allow one to understand visually how fibrous regions of hepatic parenchyma can be returned toward a normal appearance. Many examples of incomplete septal cirrhosis could be the product of regressed cirrhosis.

摘要

背景

肝硬化被广泛认为是不可逆的。最近的研究表明,如果疾病活动静止,人类和实验动物的纤维化可能会随时间减少。人类肝硬化消退的组织学表现尚未详细描述。

目的

定义表明肝硬化消退的组织学参数,并从组织学角度解释消退是如何发生的。

设计

报告一名接受了一系列活检的患者,活检显示乙肝肝硬化明显消退。此外,对52例移植时切除的患有肝硬化或不完全间隔性肝硬化的肝脏进行组织学参数分级,这些参数提示纤维化的进展或消退。进展参数包括脂肪性肝炎、炎症、桥接坏死和碎片状坏死。消退参数(统称为肝修复复合体)包括纤细的穿孔间隔、孤立的粗大胶原纤维、纤细的汇管区纤维刺、汇管区残余、伴有肝细胞脱垂的肝静脉残余、汇管区内或分隔间隔内的肝细胞、微小再生结节和异常的实质静脉。

结果与结论

在所有肝脏中均发现消退参数,且大多数肝脏中这些参数较为突出。小结节性肝硬化、大结节性肝硬化和不完全间隔性肝硬化的肝脏呈现出组织学上的连续性。在个体肝脏中也观察到了消退变化的连续性。这些表现使人们能够直观地理解肝实质的纤维区域如何恢复到正常外观。许多不完全间隔性肝硬化的例子可能是消退性肝硬化的产物。

相似文献

1
Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.人类肝硬化的消退。形态学特征及不完全间隔性肝硬化的发生机制。
Arch Pathol Lab Med. 2000 Nov;124(11):1599-607. doi: 10.5858/2000-124-1599-ROHC.
2
Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.肝硬化的逆转:在 Wanless 等人的开创性文章发表 18 年后的最新进展
Virchows Arch. 2018 Jul;473(1):15-22. doi: 10.1007/s00428-018-2340-2. Epub 2018 Mar 27.
3
Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis.谷氨酰胺合成酶免疫组化在识别退发性肝硬化特征中的应用。
Mod Pathol. 2020 Mar;33(3):448-455. doi: 10.1038/s41379-019-0346-1. Epub 2019 Aug 7.
4
Incomplete septal cirrhosis associated with Wegener's granulomatosis.与韦格纳肉芽肿相关的不完全间隔性肝硬化。
Liver. 2002 Oct;22(5):388-93. doi: 10.1034/j.1600-0676.2002.01684.x.
5
Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis.硫酸乙酰肝素蛋白聚糖和结缔组织生长因子在含有许多肥大细胞的纤维间隔中的弥漫性表达与先天性肝纤维化无法消退的肝纤维化有关。
Liver Int. 2005 Aug;25(4):817-28. doi: 10.1111/j.1478-3231.2005.01067.x.
6
Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma.
Princess Takamatsu Symp. 1995;25:179-84.
7
Incomplete septal cirrhosis: an enigmatic disease.不完全间隔性肝硬化:一种神秘的疾病。
Liver Int. 2004 Oct;24(5):452-6. doi: 10.1111/j.1478-3231.2004.0989.x.
8
Incomplete septal cirrhosis: histopathological aspects.不完全间隔性肝硬化:组织病理学特征
Histopathology. 1988 Dec;13(6):593-603. doi: 10.1111/j.1365-2559.1988.tb02091.x.
9
Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules.布加综合征的肝脏病理学:门静脉血栓形成以及中心静脉性肝硬化、门脉性肝硬化和大再生结节的组织发生学
Hepatology. 1998 Feb;27(2):488-96. doi: 10.1002/hep.510270224.
10
Hepatic microcirculation of liver cirrhosis studied by corrosion cast/scanning electron microscope examination.通过铸型腐蚀/扫描电子显微镜检查研究肝硬化的肝微循环。
Acta Pathol Jpn. 1986 Mar;36(3):375-87. doi: 10.1111/j.1440-1827.1986.tb01027.x.

引用本文的文献

1
Integrated analyses to explore the mechanism of Gancao Renshen Zhixue Decoction in treating liver cirrhosis.综合分析探讨甘草人参止血汤治疗肝硬化的机制。
Sci Rep. 2025 Jul 2;15(1):23496. doi: 10.1038/s41598-025-09206-5.
2
Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities.解读肝纤维化-肝细胞癌轴:从机制到治疗机遇
Hepatol Int. 2025 Jul 1. doi: 10.1007/s12072-025-10838-y.
3
Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease.
肝星状细胞:在健康与疾病中平衡体内稳态、肝脏保护和纤维化形成
Nat Rev Gastroenterol Hepatol. 2025 May 22. doi: 10.1038/s41575-025-01068-6.
4
A machine learning based algorithm accurately stages liver disease by quantification of arteries.一种基于机器学习的算法通过动脉量化准确地对肝脏疾病进行分期。
Sci Rep. 2025 Jan 24;15(1):3143. doi: 10.1038/s41598-025-87427-4.
5
Mechanisms and implications of recompensation in cirrhosis.肝硬化再代偿的机制及意义
JHEP Rep. 2024 Oct 10;6(12):101233. doi: 10.1016/j.jhepr.2024.101233. eCollection 2024 Dec.
6
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.非肝硬化性门脉纤维化/特发性门脉高压:亚太肝脏研究学会诊断与管理推荐意见
Hepatol Int. 2024 Dec;18(6):1684-1711. doi: 10.1007/s12072-024-10739-6. Epub 2024 Nov 15.
7
Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis.抗病毒治疗对乙型肝炎/丙型肝炎相关死亡率和纤维化消退影响的综述。
Viruses. 2024 Sep 27;16(10):1531. doi: 10.3390/v16101531.
8
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis.纤细的纤维间隔提示晚期纤维化的代谢功能障碍相关脂肪性肝炎患者有消退倾向。
Hepatol Int. 2025 Feb;19(1):166-180. doi: 10.1007/s12072-024-10719-w. Epub 2024 Aug 16.
9
Liver fibrosis: Our evolving understanding.肝纤维化:我们不断发展的认识。
Clin Liver Dis (Hoboken). 2024 Jul 3;23(1):e0243. doi: 10.1097/CLD.0000000000000243. eCollection 2024 Jan-Jun.
10
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma.探索脂滴对肝癌发生发展的影响。
Front Cell Dev Biol. 2024 May 16;12:1404006. doi: 10.3389/fcell.2024.1404006. eCollection 2024.